Poly(lactic acid)

Generic Name: Poly(lactic acid)

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: -

CAS Number: 26811-96-1

Unique Ingredient Identifier: W92NDP347A

Background: Poly(lactic acid) is under investigation in clinical trial NCT00126308 (Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy).

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Exclusive interview on 2025 physician fee schedule cuts leads November dermatology news

Healio Dermatology's top story in November focused on the CMS's 2025 physician fee schedule cuts and their impact on patient access, with FDA approvals for Emrosi, Bimzelx, and Microlyte Ag/Lidocaine also making headlines.

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy